AAMA
BIO icon

Advanced Asset Management Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Advanced Asset Management Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,300
Closed -$720K – 118
2018
Q3 		$720K Hold
2,300
– – 0.26% 80
2018
Q2 		$664K Buy
+2,300
New +$635K 0.21% 94

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Advanced Asset Management Advisors's BIO Position: Q4 2018 in Review

Advanced Asset Management Advisors sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2018, closing a stake of 2,300 shares — an estimated $720K sold.

Advanced Asset Management Advisors first reported a position in BIO in Q2 2018 and held it in 2 quarters. The position peaked at $720K in Q3 2018. 328 funds tracked by Wall St. Rank hold BIO as of Q4 2018.

  • Advanced Asset Management Advisors reported no remaining Bio-Rad Laboratories Class A position as of Q4 2018 after selling out during the quarter.
  • Advanced Asset Management Advisors sold 2,300 Bio-Rad Laboratories Class A shares in Q4 2018, an estimated $720K.
  • Advanced Asset Management Advisors first reported a position in Bio-Rad Laboratories Class A in Q2 2018 and held it in 2 quarters.
  • Advanced Asset Management Advisors's Bio-Rad Laboratories Class A position peaked at $720K in Q3 2018.
  • 328 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2018.

Based on Advanced Asset Management Advisors's 13F filing for Q4 2018, filed 4 Feb 2019.